Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 538575 of 542236 entries
View as:

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04171622 Org: User:
Start: 11/04/21 End: 08/31/25 Due: 08/31/26

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Phase: N/A Priority: Normal
NCT ID: NCT00912041 Org: User:
Start: 05/31/09 End: 12/31/38 Due: 12/31/39

Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03495973 Org: User:
Start: 10/25/17 End: 11/22/20 Due: 11/22/21

Telehealth Treatment for Opioid Use Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05832879 Org: User:
Start: 05/01/24 End: 05/31/25 Due: 05/31/26

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT05337163 Org: User:
Start: 02/25/22 End: 03/05/25 Due: 03/05/26

Linking Physiological Responses to Clinical Outcomes Following Cervical Spine Manipulation

Phase: N/A Priority: Normal
NCT ID: NCT06036849 Org: User:
Start: 09/12/23 End: 11/12/24 Due: 11/12/25

Investigation of the Effect of Nigella Sativa Oil and Sesame Oil in Preventing Phlebitis

Phase: N/A Priority: Normal
NCT ID: NCT06030141 Org: User:
Start: 11/15/23 End: 10/01/24 Due: 10/01/25

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT05815628 Org: User:
Start: 06/05/24 End: 01/01/26 Due: 01/01/27

Evaluation of the Impact of SpO2 Averaging Time on Performance of an Automatic FiO2 Control System: a Randomized Study

Phase: N/A Priority: Normal
NCT ID: NCT05274386 Org: User:
Start: 02/17/22 End: 12/30/22 Due: 12/30/23

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04691817 Org: User:
Start: 07/25/23 End: 09/30/26 Due: 09/30/27

Continuous vs. Intermittent Infusion Vancomycin

Phase: N/A Priority: Normal
NCT ID: NCT05823116 Org: User:
Start: 05/22/23 End: 12/31/25 Due: 12/31/26

Intrahospital Transport in Patients With High-flow Nasal Oxygenation: Prospective Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05311007 Org: User:
Start: 05/28/22 End: 05/04/24 Due: 05/04/25

Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients

Phase: N/A Priority: Normal
NCT ID: NCT05696132 Org: User:
Start: 11/21/24 End: 11/30/26 Due: 11/30/27

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03409614 Org: User:
Start: 03/06/18 End: 02/27/25 Due: 02/27/26

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas At Intermediate and High Risk of Recurrence.

Phase: N/A Priority: Normal
NCT ID: NCT02598219 Org: User:
Start: 11/30/15 End: 10/31/27 Due: 10/31/28

Propel Drug-Eluting Sinus Stent Family Open Cohort

Phase: N/A Priority: Normal
NCT ID: NCT05925985 Org: User:
Start: 06/01/23 End: 12/31/25 Due: 12/31/26

Effect of JAK Inhibitor on Erosion Healing in RA

Phase: N/A Priority: Normal
NCT ID: NCT05955066 Org: User:
Start: 12/01/23 End: 06/30/26 Due: 06/30/27

Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

Phase: N/A Priority: Normal
NCT ID: NCT06067139 Org: User:
Start: 08/01/23 End: 03/31/27 Due: 03/31/28

Primary Sclerosing Cholangitis in Children

Phase: N/A Priority: Normal
NCT ID: NCT04181138 Org: User:
Start: 12/30/21 End: 05/31/29 Due: 05/31/30

Single Lumen Needle Without Flushing or Double Lumen Needle With Follicle Flushing in Oocyte Retrieval

Phase: N/A Priority: Normal
NCT ID: NCT00995280 Org: User:
Start: 03/31/08 End: 11/30/08 Due: 11/30/09

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02627248 Org: User:
Start: 10/31/15 End: 10/31/25 Due: 10/31/26

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01421173 Org: User:
Start: 08/31/11 End: 09/30/15 Due: 09/30/16

Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT06264401 Org: User:
Start: 02/01/24 End: 06/02/24 Due: 06/02/25

Translation of Eye Movement Reading Training to Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01853930 Org: User:
Start: 01/01/14 End: 06/30/17 Due: 06/30/18

Study of Comparison Between Pentacam and locs3

Phase: N/A Priority: Normal
NCT ID: NCT00808886 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10